کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2493487 | 1556645 | 2013 | 6 صفحه PDF | دانلود رایگان |

In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects.This article is part of the Special Issue entitled ‘Neurodevelopmental Disorders’.
► Autism rates are increasing, and there are no biologically-validated treatments for its core symptoms.
► Adenosine-based strategies may be helpful with core symptoms and comorbidities.
► For autism with refractory epilepsy, a ketogenic diet might offer multiple benefits.
► Currently approved drugs could be tested immediately and provide adjuvant therapy.
Journal: Neuropharmacology - Volume 68, May 2013, Pages 116–121